Beranda › Glioblastoma › Virginia
Uji klinis Glioblastoma di Virginia
10 studi untuk Glioblastoma mencari peserta di lokasi di Virginia.
Kota di Virginia
Teks studi resmi (Bahasa Inggris)
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of Virginia Health, Charlottesville
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT03970447Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Inova Schar Cancer Institute, Fairfax
- VCU Massey Comprehensive Cancer Center, Richmond
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Inova Schar Cancer Institute, Fairfax
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07195591VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
- Inova Schar Cancer, Fairfax
Menerima pesertaFase 2
Usia 18 hingga 98 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07831369FearLess in NeuroOncology
- Virginia Commonwealth University, Richmond
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06989086SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville
- Inova Schar Cancer Institute, Fairfax
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05303519Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma
- University of Virginia, Charlottesville
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07343986Sonodynamic Therapy in Patients With Recurrent GBM
- University of Virginia, Charlottesville
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT06039709Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NEXT Virginia, Fairfax
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06810544SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Charlottesville
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.